{"id":"W2951051106","doi":"10.1097/01.hs9.0000559844.15284.b3","title":"PF408 DASFREE 2‐YEAR UPDATE: DASATINIB DISCONTINUATION IN PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML‐CP) AND DEEP MOLECULAR RESPONSE (DMR)","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Dasatinib; Discontinuation; Medicine; Internal medicine; Clinical endpoint; Oncology; Myeloid leukemia; Imatinib; Gastroenterology; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00265786,0.0005294745,0.00151097,0.0003909988,0.0002537895,0.001268457,0.0005663653,0.001185541,0.003988742],"category_scores_gemma":[0.002492671,0.0002835569,0.0009855265,0.0006631084,0.0001925858,0.000932548,0.0003826408,0.001849383,0.001381206],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009202342,"about_ca_system_score_gemma":0.001031575,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009864245,"about_ca_topic_score_gemma":0.00325015,"domain_scores_codex":[0.9992728,0.0002785343,0.00009413815,0.00007904384,0.0001918167,0.00008376718],"domain_scores_gemma":[0.9984335,0.0003886422,0.0006454395,0.00004780053,0.000260203,0.0002243324],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.05876002,0.001445115,0.02002904,0.004277121,0.001553871,0.0004506542,0.0002342637,0.001856906,0.00927245,0.00086107,0.1504992,0.7507603],"study_design_scores_gemma":[0.1025766,0.06291264,0.1615808,0.00196418,0.005123832,0.003707672,0.0002065289,0.004234618,0.006347694,0.002130192,0.6490422,0.0001730776],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5649923,0.2779444,0.006419436,0.04115831,0.003669899,0.002728186,0.05105085,0.001917008,0.05011963],"genre_scores_gemma":[0.8271606,0.08872402,0.006005443,0.01973458,0.003092698,0.002810462,0.04093291,0.0002544558,0.01128483],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003988742,"threshold_uncertainty_score":0.01405627,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.005851570532110407,"score_gpt":0.2490257165313177,"score_spread":0.2431741459992073,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}